cognitive cybersecurity intelligence
The final results of a phase 1/2 study of a therapy in recurrent glioblastoma multiforme (GBM) have been reported by Australian-based Telix Pharmaceuticals Ltd.
The therapy, TLX101 (4-L-[ 131I] iodo-phenylalanine, or 131I-IPA) administered with external beam radiation therapy…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
A new survey shows parents still overwhelmingly support vaccine mandates for measles and polio, as Florida moves to remove immunization requirements for school-aged children and
The Russian state-sponsored hacking group tracked as APT28 has been attributed to a new Microsoft Outlook backdoor called NotDoor in attacks targeting multiple companies from
Ethereum Smart Contracts Abused to Hide npm Malware Bitcoinsensus
The U.S. government’s termination of nearly $2.2 billion in federal grants to Harvard University violated the First Amendment and federal law, a judge for the
